-
Latest News
- Specifics of CFS coping strategies identified in a French flash survey during the COVID-19 containment
- Insights into metabolite diagnostic biomarkers for ME/CFS
- WAMES is growing to meet the challenges of 2021
- New study shows reduced ability to regulation of the cardiovascular system in patients with ME/CFS
- Dissecting the nature of Post-Exertional Malaise
Archives
Tag Archives: David Ruppert
Prospective biomarkers from plasma metabolomics of ME/CFS implicate redox imbalance in disease symptomatology
Prospective biomarkers from plasma metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome implicate Redox imbalance in disease symptomatology, by Arnaud Germain, David Ruppert, Susan M. Levine and Maureen R. Hanson in Metabolites 2018, 8(4), 90 [Published 6 Dec 2018] Research abstract: Myalgic … Continue reading →
Posted in News
|
Tagged Arnaud Germain, biomarkers, David Ruppert, Dr Maureen Hanson, Dr Susan Levine, metabolic dysfunction, redox imbalance
|
Comments Off on Prospective biomarkers from plasma metabolomics of ME/CFS implicate redox imbalance in disease symptomatology
Metabolic profiling reveals disturbances in fatty acid & lipid metabolism in ME/CFS
Research abstract: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) remains a continuum spectrum disease without biomarkers or simple objective tests, and therefore relies on a diagnosis from a set of symptoms to link the assortment of brain and body disorders to ME/CFS. … Continue reading →
Posted in News
|
Tagged Arnaud Germain, David Ruppert, Dr Susan Levine, fatty acid metabolism, fatty acids, lipid profile, metabolic profiling, Prof Maureen Hanson
|
Comments Off on Metabolic profiling reveals disturbances in fatty acid & lipid metabolism in ME/CFS